A summary and assessment of the findings and conclusions of the ESVEM trial

Progress in Cardiovascular Diseases

Volumn 38, Issue 5, 1996, Pages 347-358

  Mason, J W ^a   Marcus, F I ^a   Bigger, J T ^a   Lazzara, R ^a   Reiffel, J A ^a   Reiter, M J ^a   Mann, D ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ANTIARRHYTHMIC ACTIVITY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DRUG COST; DRUG EFFICACY; FOLLOW UP; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; SURVIVAL TIME; TREATMENT PLANNING;

EID: 0029963926     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(96)80028-4     Document Type: Article

References (56)

1. The ESVEM Investigators The ESVEM trial. Electrophysiologic study versus electrocardiographic monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias Circulation 79 1989 1354 1360
2. Graboys TB Lown B Podrid PJ Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs Am J Cardiol 50 1982 437 443
3. Swerdlow CD Winkle RA Mason JW Determinants of survival in patients with ventricular tachyarrhythmias N Engl J Med 308 1983 1436 1442
4. Mitchell LB Duff HJ Manyari DE A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia N Engl J Med 317 1987 1681 1687
5. The ESVEM Investigators Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial Circulation 87 1993 323 329
6. for the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Investigators Mason JW A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias N Engl J Med 329 1993 445 451
7. for the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) Investigators Mason JW A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias N Engl J Med 329 1993 452 458
8. Greenspan AM Determinants of antiarrhythmic drug efficacy for ventricular tachyarrhythmias using ambulatory monitoring and electrophysiological techniques Circulation 87 1993 643 645
9. Ward DE Camm AJ Dangerous ventricular arrhythmias—Can we predict drug efficacy? N Engl J Med 329 1993 498 499
10. Murgatroyd F Malignant arrhythmias: Tribulations post ESVEM Lancet 342 1993 569
11. (letter) Damle RS Ehlert FA The treatment of ventricular tachyarrhythmias N Engl J Med 330 1994 286 287
12. for the ESVEM Investigators Mason JW Response to letter N Engl J Med 330 1994 287 288
13. Biblo LA Carlson MD Waldo AL Insights into the electrophysiology study versus electrocardiographic monitoring trial: Its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy J Am Coll Cardiol 25 1995 1601 1604
14. Gettes LS ESVEM and the hazards of clinical trials Circulation 91 1995 1908 1909
15. Mason JW Implications of the ESVEM trial for use of antiarrhythmic drugs that prolong cardiac repolarization Am J Cardiol 72 1993 59F 61F
16. Klein RC the ESVEM Investigators Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: Results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial Eur Heart J 14 suppl H 1993 78 84
17. Campbell RWF Interpretation of the results of the electrophysiologic study versus electrocardiographic monitoring (ESVEM) study: Impact on algorithm for drug selection Coron ARtery Dis 5 1994 682 685
18. d'Avila A Fenelon G Nellens P Interpretation of the results of the electrophysiologic study versus electrocardiographic monitoring (ESVEM) study: Electrocardiographic monitoring advocates' view Coron Artery Dis 5 1994 677 681
19. Mitchell LB Wyse DG Interpretation of the results of the electrophysiologic study versus electrocardiographic monitoring (ESVEM) study: Programmed ventricular stimulation advocates' view Coron Artery Dis 5 1994 671 676
20. Lazzara R Results of Holter ECG guided therapy for ventricular arrhythmias: The ESVEM trial PACE 17 1994 473 477
21. for the ESVEM Investigators Omoigui NA Marcus FI Mason JW Cost of initial therapy in the electrophysiologic study versus electrocardiographic monitoring trial (ESVEM) Circulation 91 1995 1070 1076
22. Reiter MJ Mann DE the ESVEM Investigators Significance and incidence of concordance of drug efficacy predictions by Holter monitoring and electrophysiologic study in the ESVEM trial Circulation 91 1995 1988 1995
23. Anderson K Electrophysiologic study versus electrocardiographic monitoring trial and the role of electrophysiologic study in the management of patients with ventricular tachyarrhythmias J Ambulat Monitor 8 1995 185 196
24. for the ESVEM Investigators Anderson KP Walker R Dustman T Spontaneous sustained ventricular tachycardia in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial J Am Coll Cardiol 26 1995 489 496
25. Hlatky MA, Boothroyd D, Johnstone I, et al, for the ESVEM Investigators: Long-term cost-effectiveness of alternative management strategies for patients with life-threatening ventricular arrhythmias. J Clin Epidemiol (manuscript submitted)
26. abstr Caruso AC Hahn EA the ESVEM Investigators Predictors of arrhythmic death and cardiac arrest in the ESVEM study Circulation 88 suppl I 1993 I 606
27. abstr Reiffel JA Reiter M the ESVEM Investigators Did the number of premature stimuli used or the length of unsustained tachycardia induced affect the predictive accuracy of the electrophysiologic study used to guide therapy in the ESVEM trial PACE 17 suppl II 1994 826
28. (abstr) Reiter MJ Mann DE Reiffel JE the ESVEM Investigators Reproducibility of drug efficacy prediction by Holter monitoring in the ESVEM trial Circulation 90 1994 I 179
29. (abstr) Olshansky B Hahn E Hartz V the ESVEM Investigators Is syncope in the ESVEM trial a marker of cardiac arrest or all cause mortality? Circulation 90 1994 I 456
30. abstr Reiffel JA Hahn E the ESVEM Investigators Was the superiority of sotalol in the ESVEM trial due to its beta blocking effects? PACE 18 suppl II 1995 811
31. for the ESVEM Investigators Freedman RA Steinberg JS Selective prolongation of QRS late potentials by sodium channel blocking antiarrhythmic drugs: relation to slowing of ventricular tachycardia J Am Coll Cardiol 17 1991 1017 1025
32. with data contributed by the CAPS and ESVEM Investigators Bigger JT Jr Fleiss JL Rolnitzky LM Stability over time of heart period variability in patients with previous myocardial infarction and ventricular arrhythmias Am J Cardiol 69 1992 718 723
33. Steinberg JS Freedman RA the ESVEM Investigators Antiarrhythmic drug therapy and the signal-averaged electrocardiogram El-Sherif N Turitto G High-Resolution Electrocardiography 1992 Futura Mount Kisco, NY 569 590
34. abstr Mason JW the ESVEM Investigators Unsustained VT as a predictor of spontaneous sustained VT in the ESVEM study Circulation 84 suppl II 1991 II 348
35. Reiffel JA Reiter MJ Freedman RA the ESVEM Investigators Influence of Holter monitor and electrophysiologic study methods and the efficacy criteria on the outcome of ventricular tachycardia and ventricular fibrillation patients in the ESVEM trial Prog Cardiovasc Dis 38 1996 359 370
36. Steinbeck G Andersen D Bach P A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias N Engl J Med 327 1992 987 992
37. The ESVEM trial Directions in ventricular tachyarrhythmia management. Videotape moderated by SL Weinberg Medical Communications Resources, Inc 1993
38. The CASCADE Investigators Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study) Am J Cardiol 72 1993 280 287
39. CAPS Investigators The cardiac arrhythmia pilot study Am J Cardiol 57 1986 91 95
40. Morganroth J Michelson EL Horowitz LN Limitations of routine long term electrocardiographic monitoring to assess ventricular ectopic frequency Circulation 58 1978 408 414
41. Kim SG Seiden SW Matos JA Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia J Am Coll Cardiol 6 1985 339 344
42. Anderson J Implantable defibrillators are preferable to pharmacologic therapy for patients with ventricular tachyarrhythmias Prog Cardiovasc Dis 38 1996 393 400
43. (response to letter) Lown B Graboys TB Podrid PJ Holter versus electrophysiologic studies in the management of malignant ventricular arrhythmias Am J Cardiol 51 1983 1465 1466
44. Swerdlow CD Peterson J Prospective comparison of Holter monitoring and electrophysiologic study in patients with coronary artery disease and sustained ventricular tachyarrhythmias Am J Cardiol 56 1985 577 580
45. Maloney J CPI AICD Advances Fourth quarter 1992 8 10
46. Rae AP Greenspan AM Spielman SR Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies Am J Cardiol 55 1985 1494 1499
47. Borggrefe M Trampisch HJ Breithardt G Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: Complete versus partial suppression of inducible arrhythmias J Am Coll Cardiol 12 1988 140 149
48. (letter) Winters SL Rubinstein D Gomes JA The treatment of ventricular tachyarrhythmias N Engl J Med 330 1994 287
49. Ferrick K Luce J Miller S Reproducibility of electrophysiologic testing during antiarrhythmic therapy for ventricular arrhythmias secondary to coronary artery disease Am J Cardiol 69 1992 1296 1299
50. Josephson M Clinical Cardiac Electrophysiology, Techniques and Interpretation ed 2 1993 Lea & Febiger Philadelphia, PA 643 645
51. Saksena S, Breithardt G, Dorian P, et al: Nonpharmacological therapy for malignant ventricular arrhythmias: Implantable defibrillator trials. Prog Cardiovasc Dis (in press)
52. Saksena S, Madan N, Lewis C: Implantable cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis (in press)
53. Cain ME Management of sustained ventricular arrhythmias. Overview Corn Artery Dis 5 1994 650 652
54. Siebels J Cappato R Rudolf R Preliminary results of the cardiac arrest study Hamburg (CASH) Am J Cardiol 72 1993 109F 113F
55. The AVID Investigators Antiarrhythmics versus implantable defibrillators (AVID)—Rationale, design, and methods Am J Cardiol 75 1995 470 475
56. Connolly SJ Gent M Roberts RS Canadian implantable defibrillator study (CIDS): Study design and organization Am J Cardiol 72 1993 103F 108F